Michael Hotchkin
Corporate Officer/Principal chez CLENE INC.
Profil
Michael Hotchkin is currently the Chief Development Officer at Clene, Inc. He previously worked as a Member at Actelion Pharmaceuticals US, Inc. He completed his undergraduate degree at Pepperdine University in 1996.
Postes actifs de Michael Hotchkin
| Sociétés | Poste | Début |
|---|---|---|
| CLENE INC. | Corporate Officer/Principal | - |
Anciens postes connus de Michael Hotchkin
| Sociétés | Poste | Fin |
|---|---|---|
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | - |
Formation de Michael Hotchkin
| Pepperdine University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CLENE INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
